Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection

Fig. 2

Projected uptake of oral PrEP, vaginal ring and injectable ARVs amongst adolescent (a) and adult women (b), and resulting effect on levels of condom use. The percentage of women using no product for each phase is also shown. The products are assumed to be introduced in four phases, with oral PrEP becoming available first, then the vaginal ring, and injectable ARVs (these 3 are assumed to be just HIV efficacious), and then phase 4 has the same products but with pregnancy and STI efficacy included. a. Adolescent women. b. Adult women

Back to article page
\